title: Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men.
abstract: Melatonin and leptin exhibit daily rhythms that may contribute towards changes in metabolic physiology. It remains unclear, however, whether this rhythmicity is altered in obesity or type 2 diabetes (T2DM). We tested the hypothesis that 24-hour profiles of melatonin, leptin and leptin mRNA are altered by metabolic status in laboratory conditions. Men between 45-65 years old were recruited into lean, obese-non-diabetic or obese-T2DM groups. Volunteers followed strict sleep-wake and dietary regimes for 1 week before the laboratory study. They were then maintained in controlled light-dark conditions, semi-recumbent posture and fed hourly iso-energetic drinks during wake periods. Hourly blood samples were collected for hormone analysis. Subcutaneous adipose biopsies were collected 6-hourly for gene expression analysis. Although there was no effect of subject group on the timing of dim light melatonin onset (DLMO), nocturnal plasma melatonin concentration was significantly higher in obese-non-diabetic subjects compared to weight-matched T2DM subjects (p<0.01) and lean controls (p<0.05). Two T2DM subjects failed to produce any detectable melatonin, although did exhibit plasma cortisol rhythms comparable to others in the group. Consistent with the literature, there was a significant (p<0.001) effect of subject group on absolute plasma leptin concentration and, when expressed relative to an individual's 24-hour mean, plasma leptin showed significant (p<0.001) diurnal variation. However, there was no difference in amplitude or timing of leptin rhythms between experimental groups. There was also no significant effect of time on leptin mRNA expression. Despite an overall effect (p<0.05) of experimental group, post-hoc analysis revealed no significant pair-wise effects of group on leptin mRNA expression. Altered plasma melatonin rhythms in weight-matched T2DM and non-diabetic individuals supports a possible role of melatonin in T2DM aetiology. However, neither obesity nor T2DM changed 24-hour rhythms of plasma leptin relative to cycle mean, or expression of subcutaneous adipose leptin gene expression, compared with lean subjects.
authors.affiliation: Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
authors.forename: Simone
authors.initials: S
authors.lastname: Mäntele
authors.forename: Daniella T
authors.initials: DT
authors.lastname: Otway
authors.forename: Benita
authors.initials: B
authors.lastname: Middleton
authors.forename: Silvia
authors.initials: S
authors.lastname: Bretschneider
authors.forename: John
authors.initials: J
authors.lastname: Wright
authors.forename: M Denise
authors.initials: MD
authors.lastname: Robertson
authors.forename: Debra J
authors.initials: DJ
authors.lastname: Skene
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Johnston
mesh_terms: D000704:Analysis of Variance; D002940:Circadian Rhythm / Q000502:physiology*; D017931:DNA Primers / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000503:physiopathology; D020869:Gene Expression Profiling; D006801:Humans; D020738:Leptin / Q000097:blood* / Q000235:genetics; D008297:Male; D008550:Melatonin / Q000097:blood*; D008875:Middle Aged; D009765:Obesity / Q000097:blood* / Q000503:physiopathology; D012333:RNA, Messenger / Q000097:blood*; D011863:Radioimmunoassay; D013851:Thinness / Q000097:blood* / Q000503:physiopathology
chemical_list: D017931:DNA Primers; D020738:Leptin; D012333:RNA, Messenger; D008550:Melatonin